Stone Formation Linked to Hemoglobin A1c Levels
Finding could explain the association between obesity and diabetes and the development of kidney stones.
Diagnosis & Disease Information
Recurrence of Low-Risk RCC Uncommon After Surgery
In a study, the 5-year risk of recurrence was 4.8%, 18.1%, and 46.3% for patients with low-, intermediate-, and high-risk disease.
Prostate Cancer Active Surveillance Does Not Up Metastasis Risk
Study finds no difference in metastasis-free survival observed after 15 years compared with radiation therapy or radical prostatectomy.
Bladder Surgery Complications Predicted by New Model
Nomograms specific to radical cystectomy currently do not exist to aid stratification of a patient’s risks for complications.
Biologics Combo Shows Promise As First-Line mRCC Therapy
In a phase 2 trial, atezolizumab plus bevacizumab improved PFS versus sunitinib in patients with renal cell carcinoma expressing PD-L1.
Sunitinib Dose Escalation May Benefit mRCC Patients
Added progression-free survival and prolonged overall survival possible, according to investigators.
Kidney Cancer Brain Metastases Not On the Rise
Researchers develop a model to predict which patients are more likely to harbor brain metastases at cancer diagnosis.
Single RCC Bone Metastasis Predicts Better Survival
Bone surgery should be considered in patients with solitary bone metastasis and no concomitant visceral metastases, according to investigators.
PFS Longer With Abiraterone As Second-Line mCRPC Treatment
Clinical or radiologic progression is less likely with abiraterone plus prednisone than cabazitaxel following first-line docetaxel, study finds.
PSA, PSAD Less Predictive of Aggressive PCa in Black Men
Study finds that PSA and PSAD indicated prostate cancer above Gleason score 6 for white men only.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...